Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Polly Fish"'
Autor:
C. Michael Gibson, Venu Menon, Ivan C. Rokos, Nicolas W. Shammas, Steve C. Rohrbeck, Eugene Braunwald, Ajay J. Kirtane, Samer Kazziha, Jeffrey Lins, Carolyn H. McCabe, Sabina A. Murphy, Theresa M. Palabrica, Polly Fish
Publikováno v:
American Heart Journal. 152:668-675
Background Early restoration of epicardial flow before primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) has been associated with improved clinical outcomes. Methods We hypothesized that early adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b99ddfed5fae0b21605af5a042bfca
https://doi.org/10.1016/j.ahj.2006.06.003
https://doi.org/10.1016/j.ahj.2006.06.003
Autor:
David A. Morrow, Peter Stone, Carolyn H. McCabe, Theresa M. Palabrica, Henry H. Lui, Polly Fish, Eugene Braunwald, C. Michael Gibson, Sabina A. Murphy, Lisa K. Jennings, Nasser Lakkis, David J. Cohen, Richard Kovach, Thomas M Bulle
Publikováno v:
Journal of the American College of Cardiology. 47:2364-2373
OBJECTIVES The goal of this study was to evaluate glycoprotein IIb/IIIa inhibition with eptifibatide when administered with indirect thrombin inhibition as compared with monotherapy with direct thrombin inhibition with bivalirudin among patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::361b621d9d1b4f7ae3a06dd99d850b8b
https://doi.org/10.1016/j.jacc.2005.12.077
https://doi.org/10.1016/j.jacc.2005.12.077
Autor:
C Michael, Gibson, David A, Morrow, Sabina A, Murphy, Theresa M, Palabrica, Lisa K, Jennings, Peter H, Stone, Henry H, Lui, Thomas, Bulle, Nasser, Lakkis, Richard, Kovach, David J, Cohen, Polly, Fish, Carolyn H, McCabe, Eugene, Braunwald
Publikováno v:
Journal of the American College of Cardiology. 47(12)
The goal of this study was to evaluate glycoprotein IIb/IIIa inhibition with eptifibatide when administered with indirect thrombin inhibition as compared with monotherapy with direct thrombin inhibition with bivalirudin among patients with non-ST-seg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e676b7ece6a336b0eff0d3dd76236414
https://pubmed.ncbi.nlm.nih.gov/17291940
https://pubmed.ncbi.nlm.nih.gov/17291940
Autor:
David A, Morrow, Benjamin M, Scirica, Keith A A, Fox, Gail, Berman, John, Strony, Enrico, Veltri, Marc P, Bonaca, Polly, Fish, Carolyn H, McCabe, Eugene, Braunwald, Joseph, Vita
Publikováno v:
American Heart Journal. 158:335-341.e3
Background Thrombin potently activates platelets via interaction with the protease-activated receptor 1. SCH 530348 is a novel antiplatelet agent that selectively inhibits the cellular actions of thrombin via antagonism of the protease-activated rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f523013a8655d3b867f949ff8c398e27
https://doi.org/10.1016/j.ahj.2009.06.027
https://doi.org/10.1016/j.ahj.2009.06.027